Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Immune Resistance and EGFR Antagonists in Colorectal Cancer.

Giordano G, Remo A, Porras A, Pancione M.

Cancers (Basel). 2019 Jul 31;11(8). pii: E1089. doi: 10.3390/cancers11081089. Review.

2.

Morphology and Molecular Features of Rare Colorectal Carcinoma Histotypes.

Remo A, Fassan M, Vanoli A, Bonetti LR, Barresi V, Tatangelo F, Gafà R, Giordano G, Pancione M, Grillo F, Mastracci L.

Cancers (Basel). 2019 Jul 23;11(7). pii: E1036. doi: 10.3390/cancers11071036. Review.

3.

CROCC-mutated rhabdoid colorectal carcinoma showing in intercellular spaces lamellipodia and cellular projections revealed by electron microscopy.

Remo A, Cecchini MP, Benati D, Bernardi P, Manfrin E, Giordano G, Bonomi F, Parcesepe P, Fassan M, Colombari R, Sbarbati A, Pancione M.

Virchows Arch. 2019 Aug;475(2):245-249. doi: 10.1007/s00428-019-02554-4. Epub 2019 Mar 10.

PMID:
30852641
4.

JAK/Stat5-mediated subtype-specific lymphocyte antigen 6 complex, locus G6D (LY6G6D) expression drives mismatch repair proficient colorectal cancer.

Giordano G, Parcesepe P, D'Andrea MR, Coppola L, Di Raimo T, Remo A, Manfrin E, Fiorini C, Scarpa A, Amoreo CA, Conciatori F, Milella M, Caruso FP, Cerulo L, Porras A, Pancione M.

J Exp Clin Cancer Res. 2019 Jan 22;38(1):28. doi: 10.1186/s13046-018-1019-5.

5.

Crosstalk between the Tumor Microenvironment and Immune System in Pancreatic Ductal Adenocarcinoma: Potential Targets for New Therapeutic Approaches.

Parente P, Parcesepe P, Covelli C, Olivieri N, Remo A, Pancione M, Latiano TP, Graziano P, Maiello E, Giordano G.

Gastroenterol Res Pract. 2018 Dec 18;2018:7530619. doi: 10.1155/2018/7530619. eCollection 2018. Review.

6.

Urothelial bladder carcinoma metastasizing to the eye: A systematic review and case report.

Giordano G, Olivieri N, D'Andrea MR, Di Raimo T, Manfrin E, Remo A, Pancione M, Brunelli M, De Santis E, Coppola G, Scarpa A, Coppola L, Parcesepe P.

Oncol Lett. 2019 Jan;17(1):462-467. doi: 10.3892/ol.2018.9579. Epub 2018 Oct 15.

7.

Colonic Ewing Sarcoma/PNET associated with liver metastases: A systematic review and case report.

Parcesepe P, Giordano G, Zanella C, Giuliani J, Greco F, Bonetti A, Pancione M, Manfrin E, Molinari E, Latiano TP, D'Andrea MR, Fassan M, Olivieri N, Remo A.

Pathol Res Pract. 2019 Feb;215(2):387-391. doi: 10.1016/j.prp.2018.11.021. Epub 2018 Nov 29.

PMID:
30553605
8.

Centrosome Linker-induced Tetraploid Segregation Errors Link Rhabdoid Phenotypes and Lethal Colorectal Cancers.

Remo A, Manfrin E, Parcesepe P, Ferrarini A, Han HS, Mickys U, Laudanna C, Simbolo M, Malanga D, Oliveira DM, Baritono E, Colangelo T, Sabatino L, Giuliani J, Molinari E, Garonzi M, Xumerle L, Delledonne M, Giordano G, Ghimenton C, Lonardo F, D'angelo F, Grillo F, Mastracci L, Viglietto G, Ceccarelli M, Colantuoni V, Scarpa A, Pancione M.

Mol Cancer Res. 2018 Sep;16(9):1385-1395. doi: 10.1158/1541-7786.MCR-18-0062. Epub 2018 May 21.

9.

Nano albumin bound-paclitaxel in pancreatic cancer: Current evidences and future directions.

Giordano G, Pancione M, Olivieri N, Parcesepe P, Velocci M, Di Raimo T, Coppola L, Toffoli G, D'Andrea MR.

World J Gastroenterol. 2017 Aug 28;23(32):5875-5886. doi: 10.3748/wjg.v23.i32.5875. Review.

10.

Clear cell colorectal carcinoma: Time to clarify diagnosis.

Remo A, Grillo F, Mastracci L, Fassan M, Sina S, Zanella C, Parcesepe P, Damiano Urso E, Pancione M, Bortuzzo G, Scarpa A, Manfrin E.

Pathol Res Pract. 2017 May;213(5):447-452. doi: 10.1016/j.prp.2017.02.013. Epub 2017 Feb 24. Review.

PMID:
28285963
11.

Emerging Insight into MAPK Inhibitors and Immunotherapy in Colorectal Cancer.

Pancione M, Giordano G, Parcesepe P, Cerulo L, Coppola L, Curatolo AD, Conciatori F, Milella M, Porras A.

Curr Med Chem. 2017;24(14):1383-1402. doi: 10.2174/0929867324666170227114356. Review.

PMID:
28245767
12.

Aberrant BLM cytoplasmic expression associates with DNA damage stress and hypersensitivity to DNA-damaging agents in colorectal cancer.

Votino C, Laudanna C, Parcesepe P, Giordano G, Remo A, Manfrin E, Pancione M.

J Gastroenterol. 2017 Mar;52(3):327-340. doi: 10.1007/s00535-016-1222-0. Epub 2016 May 11.

PMID:
27169843
13.

Cancer drug related cardiotoxicity during breast cancer treatment.

Giordano G, Spagnuolo A, Olivieri N, Corbo C, Campagna A, Spagnoletti I, Pennacchio RM, Campidoglio S, Pancione M, Palladino L, Villari B, Febbraro A.

Expert Opin Drug Saf. 2016 Aug;15(8):1063-74. doi: 10.1080/14740338.2016.1182493. Epub 2016 Jul 6. Review.

PMID:
27120499
14.

Cancer-Associated Immune Resistance and Evasion of Immune Surveillance in Colorectal Cancer.

Parcesepe P, Giordano G, Laudanna C, Febbraro A, Pancione M.

Gastroenterol Res Pract. 2016;2016:6261721. doi: 10.1155/2016/6261721. Epub 2016 Feb 23. Review.

15.

Proteomic screening identifies calreticulin as a miR-27a direct target repressing MHC class I cell surface exposure in colorectal cancer.

Colangelo T, Polcaro G, Ziccardi P, Pucci B, Muccillo L, Galgani M, Fucci A, Milone MR, Budillon A, Santopaolo M, Votino C, Pancione M, Piepoli A, Mazzoccoli G, Binaschi M, Bigioni M, Maggi CA, Fassan M, Laudanna C, Matarese G, Sabatino L, Colantuoni V.

Cell Death Dis. 2016 Feb 25;7:e2120. doi: 10.1038/cddis.2016.28.

16.

Case Report of a Well-Differentiated Papillary Mesothelioma of the Tunica Vaginalis in an Undescended Testis With Review of Literature.

Parcesepe P, Sina S, Zanella C, Pancione M, Giuliani J, Detogni P, Curti P, Bonetti A, Manfrin E, Remo A.

Int J Surg Pathol. 2016 Aug;24(5):443-7. doi: 10.1177/1066896916628279. Epub 2016 Feb 12. Review.

PMID:
26873338
17.

Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in metastatic colorectal cancer.

Giordano G, Febbraro A, Tomaselli E, Sarnicola ML, Parcesepe P, Parente D, Forte N, Fabozzi A, Remo A, Bonetti A, Manfrin E, Ghasemi S, Ceccarelli M, Cerulo L, Bazzoni F, Pancione M.

J Exp Clin Cancer Res. 2015 Oct 1;34:108. doi: 10.1186/s13046-015-0225-7.

18.

Systems biology analysis reveals NFAT5 as a novel biomarker and master regulator of inflammatory breast cancer.

Remo A, Simeone I, Pancione M, Parcesepe P, Finetti P, Cerulo L, Bensmail H, Birnbaum D, Van Laere SJ, Colantuoni V, Bonetti F, Bertucci F, Manfrin E, Ceccarelli M.

J Transl Med. 2015 May 1;13:138. doi: 10.1186/s12967-015-0492-2.

19.

p16 Expression in Prostate Cancer and Nonmalignant Lesions: Novel Findings and Review of the Literature.

Remo A, Pancione M, Zanella C, Manfrin E.

Appl Immunohistochem Mol Morphol. 2016 Mar;24(3):201-6. doi: 10.1097/PAI.0000000000000171. Review.

PMID:
25906117
20.

Targeting angiogenesis and tumor microenvironment in metastatic colorectal cancer: role of aflibercept.

Giordano G, Febbraro A, Venditti M, Campidoglio S, Olivieri N, Raieta K, Parcesepe P, Imbriani GC, Remo A, Pancione M.

Gastroenterol Res Pract. 2014;2014:526178. doi: 10.1155/2014/526178. Epub 2014 Jul 21. Review.

21.

Comparison between invasive breast cancer with extensive peritumoral vascular invasion and inflammatory breast carcinoma: a clinicopathologic study of 161 cases.

Manfrin E, Remo A, Pancione M, Cannizzaro C, Falsirollo F, Pollini GP, Pellini F, Molino A, Brunelli M, Vendraminelli R, Ceccarelli M, Pagnotta SM, Simeone I, Bonetti F.

Am J Clin Pathol. 2014 Sep;142(3):299-306. doi: 10.1309/AJCPOXKX67KRAOVM.

PMID:
25125618
22.

Emerging role of the β-catenin-PPARγ axis in the pathogenesis of colorectal cancer.

Sabatino L, Pancione M, Votino C, Colangelo T, Lupo A, Novellino E, Lavecchia A, Colantuoni V.

World J Gastroenterol. 2014 Jun 21;20(23):7137-51. doi: 10.3748/wjg.v20.i23.7137. Review.

23.

Immune escape mechanisms in colorectal cancer pathogenesis and liver metastasis.

Pancione M, Giordano G, Remo A, Febbraro A, Sabatino L, Manfrin E, Ceccarelli M, Colantuoni V.

J Immunol Res. 2014;2014:686879. doi: 10.1155/2014/686879. Epub 2014 Jan 16. Review.

24.

A specific DNA methylation profile correlates with a high risk of disease progression in stage I classical (Alibert-Bazin type) mycosis fungoides.

Ferrara G, Pancione M, Votino C, Quaglino P, Tomasini C, Santucci M, Pimpinelli N, Cusano F, Sabatino L, Colantuoni V.

Br J Dermatol. 2014 Jun;170(6):1266-75. doi: 10.1111/bjd.12717. Epub 2014 Jun 6.

PMID:
24641245
25.

Peroxisome proliferator-activated receptor γ-mediated induction of microRNA-145 opposes tumor phenotype in colorectal cancer.

Panza A, Votino C, Gentile A, Valvano MR, Colangelo T, Pancione M, Micale L, Merla G, Andriulli A, Sabatino L, Vinciguerra M, Prattichizzo C, Mazzoccoli G, Colantuoni V, Piepoli A.

Biochim Biophys Acta. 2014 Jun;1843(6):1225-36. doi: 10.1016/j.bbamcr.2014.03.003. Epub 2014 Mar 11.

26.

The chromatin remodelling component SMARCB1/INI1 influences the metastatic behavior of colorectal cancer through a gene signature mapping to chromosome 22.

Pancione M, Remo A, Zanella C, Sabatino L, Di Blasi A, Laudanna C, Astati L, Rocco M, Bifano D, Piacentini P, Pavan L, Purgato A, Greco F, Talamini A, Bonetti A, Ceccarelli M, Vendraminelli R, Manfrin E, Colantuoni V.

J Transl Med. 2013 Nov 28;11:297. doi: 10.1186/1479-5876-11-297.

27.

Ensemble of gene signatures identifies novel biomarkers in colorectal cancer activated through PPARγ and TNFα signaling.

Pagnotta SM, Laudanna C, Pancione M, Sabatino L, Votino C, Remo A, Cerulo L, Zoppoli P, Manfrin E, Colantuoni V, Ceccarelli M.

PLoS One. 2013 Aug 19;8(8):e72638. doi: 10.1371/journal.pone.0072638. eCollection 2013.

28.

MicroRNA-130b promotes tumor development and is associated with poor prognosis in colorectal cancer.

Colangelo T, Fucci A, Votino C, Sabatino L, Pancione M, Laudanna C, Binaschi M, Bigioni M, Maggi CA, Parente D, Forte N, Colantuoni V.

Neoplasia. 2013 Sep;15(9):1086-99.

29.

Lung metastasis from TTF-1 positive sigmoid adenocarcinoma. pitfalls and management.

Remo A, Zanella C, Pancione M, Astati L, Piacentini P, Cingarlini S, Bonetti A, Micheletto C, Talamini A, Chilosi M, Vendraminelli R, Manfrin E.

Pathologica. 2013 Apr;105(2):69-72.

PMID:
23946985
30.

Molecular pathology of colorectal carcinoma. A systematic review centred on the new role of the pathologist.

Remo A, Pancione M, Zanella C, Vendraminelli R.

Pathologica. 2012 Dec;104(6):432-41. Review.

PMID:
23547429
31.

Right-sided rhabdoid colorectal tumors might be related to the serrated pathway.

Pancione M, Remo A, Sabatino L, Zanella C, Votino C, Fucci A, Di Blasi A, Lepore G, Daniele B, Fenizia F, Molinari E, Normanno N, Manfrin E, Vendraminelli R, Colantuoni V.

Diagn Pathol. 2013 Feb 20;8:31. doi: 10.1186/1746-1596-8-31.

32.

The role of peroxisome proliferator-activated receptors in the esophageal, gastric, and colorectal cancer.

Fucci A, Colangelo T, Votino C, Pancione M, Sabatino L, Colantuoni V.

PPAR Res. 2012;2012:242498. Epub 2012 Sep 6.

33.

Genetic and epigenetic events generate multiple pathways in colorectal cancer progression.

Pancione M, Remo A, Colantuoni V.

Patholog Res Int. 2012;2012:509348. doi: 10.1155/2012/509348. Epub 2012 Jul 24.

34.

PPARG Epigenetic Deregulation and Its Role in Colorectal Tumorigenesis.

Sabatino L, Fucci A, Pancione M, Colantuoni V.

PPAR Res. 2012;2012:687492. doi: 10.1155/2012/687492. Epub 2012 Jul 16.

35.

UHRF1 coordinates peroxisome proliferator activated receptor gamma (PPARG) epigenetic silencing and mediates colorectal cancer progression.

Sabatino L, Fucci A, Pancione M, Carafa V, Nebbioso A, Pistore C, Babbio F, Votino C, Laudanna C, Ceccarelli M, Altucci L, Bonapace IM, Colantuoni V.

Oncogene. 2012 Dec 6;31(49):5061-72. doi: 10.1038/onc.2012.3. Epub 2012 Jan 30.

PMID:
22286757
36.

A novel case of rhabdoid colon carcinoma associated with a positive CpG island methylator phenotype and BRAF mutation.

Pancione M, Di Blasi A, Sabatino L, Fucci A, Dalena AM, Palombi N, Carotenuto P, Aquino G, Daniele B, Normanno N, Colantuoni V.

Hum Pathol. 2011 Jul;42(7):1047-52. doi: 10.1016/j.humpath.2010.10.016. Epub 2011 Feb 11.

PMID:
21315413
37.

CDKN1B V109G polymorphism a new prognostic factor in sporadic medullary thyroid carcinoma.

Pasquali D, Circelli L, Faggiano A, Pancione M, Renzullo A, Elisei R, Romei C, Accardo G, Coppola VR, De Palma M, Ferolla P, Grimaldi F, Colao A, Colantuoni V.

Eur J Endocrinol. 2011 Mar;164(3):397-404. doi: 10.1530/EJE-10-0929. Epub 2010 Dec 21.

PMID:
21177330
38.

Epigenetic silencing of peroxisome proliferator-activated receptor γ is a biomarker for colorectal cancer progression and adverse patients' outcome.

Pancione M, Sabatino L, Fucci A, Carafa V, Nebbioso A, Forte N, Febbraro A, Parente D, Ambrosino C, Normanno N, Altucci L, Colantuoni V.

PLoS One. 2010 Dec 3;5(12):e14229. doi: 10.1371/journal.pone.0014229. Erratum in: PLoS One. 2011;6(1). doi: 10.1371/annotation/07419a37-33f1-4e4a-adc9-b186f305bae5.

39.

The high expression of p53 in sporadic colorectal carcinoma is associated with metastasis and decreased survival.

Pancione M, Forte N, Campione S, Napolitano A, Parente D, Sabatino L, Febbraro A, Colantuoni V.

Pathologica. 2010 Apr;102(2):51-6.

PMID:
23596757
40.

Prognostic role of beta-catenin and p53 expression in the metastatic progression of sporadic colorectal cancer.

Pancione M, Forte N, Fucci A, Sabatino L, Febbraro A, Di Blasi A, Daniele B, Parente D, Colantuoni V.

Hum Pathol. 2010 Jun;41(6):867-76. doi: 10.1016/j.humpath.2009.09.019. Epub 2010 Feb 4.

PMID:
20129645
41.

A novel germline mutation in peroxisome proliferator-activated receptor gamma gene associated with large intestine polyp formation and dyslipidemia.

Capaccio D, Ciccodicola A, Sabatino L, Casamassimi A, Pancione M, Fucci A, Febbraro A, Merlino A, Graziano G, Colantuoni V.

Biochim Biophys Acta. 2010 Jun;1802(6):572-81. doi: 10.1016/j.bbadis.2010.01.012. Epub 2010 Feb 1.

42.

Reduced beta-catenin and peroxisome proliferator-activated receptor-gamma expression levels are associated with colorectal cancer metastatic progression: correlation with tumor-associated macrophages, cyclooxygenase 2, and patient outcome.

Pancione M, Forte N, Sabatino L, Tomaselli E, Parente D, Febbraro A, Colantuoni V.

Hum Pathol. 2009 May;40(5):714-25. doi: 10.1016/j.humpath.2008.08.019. Epub 2009 Jan 3.

PMID:
19121846

Supplemental Content

Loading ...
Support Center